Conclusion of Memorandum of Understanding with Medgaea Life Sciences Ltd. for Cooperative Relationship

On August 3, 2018, at the Taiwan 2018 Latest Business Seminar in Tokyo, SNBL and Medgaea Life Sciences Ltd. (MDG) signed a Memorandum of Understanding (MOU). The MOU, signed by Dr. Chih-Chun Hong, Chief Executive Officer of MDG, and Koichiro Fukuzaki, Executive Vice Chairman of SNBL, confirms the intention of SNBL and MDG to collaborate more closely.

 

MDG was established in Taiwan in 2005 and offers a variety of pre-clinical contract research services for health foods, herbal medicine, medical devices, and chemical products.  SNBL and MDG will promote and support R&D of drugs, medical devices, and regenerative medicine in Taiwan.